Moderna files for COVID-19 vaccine EUA in Philippines
American drug firm Moderna filed an application for emergency use authorization (EUA) of its COVID-19 vaccine in the Philippines on Monday, April 26.
FDA Director General Eric Domingo confirmed the filing and said it is a significant step towards making the vaccine available to Filipinos from May to June.
Vaccine czar Carlito Galvez Jr. announced during the Sulong Pilipinas Forum that Moderna submitted its application through Zuellig Pharma Corp.
The FDA will take at least 21 days to review the trial data and other information before approving the vaccine for public use.
Moderna is the eighth company to apply for EUA in the Philippines, with approval potentially making it the seventh available vaccine.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics